Professional
Added to YB: 2024-02-26
Pitch date: 2024-01-15
ABT [bullish]
Abbott Laboratories
-19.12%
current return
Author Info
No bio for this author
Upgrade to Yellowbrick Premium to unlock investor returns. Upgrade to Yellowbrick Premium
Company Info
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide.
Market Cap
$153.9B
Pitch Price
$108.51
Price Target
N/A
Dividend
2.85%
EV/EBITDA
14.95
P/E
24.76
EV/Sales
4.02
Sector
Health Care Equipment and Supplies
Category
growth
Show full summary:
Polen Global Growth Added to Existing Position - Abbott Laboratories
Abbott Labs: Increased position in dominant healthcare co. despite COVID test sales pressure. Core biz strong, stock cheaper now. Believe in long-term growth prospects, making it attractive investment at current valuation.
Read full article (1 min)